<VariationArchive VariationID="253129" VariationName="NM_198334.3(GANAB):c.1848_1849del (p.Asp618fs)" VariationType="Deletion" Accession="VCV000253129" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-08" DateCreated="2018-02-25" MostRecentSubmission="2021-07-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="247541" VariationID="253129">
      <GeneList>
        <Gene Symbol="GANAB" FullName="glucosidase II alpha subunit" GeneID="23193" HGNC_ID="HGNC:4138" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62624829" stop="62646613" display_start="62624829" display_stop="62646613" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="62392297" stop="62414103" display_start="62392297" display_stop="62414103" Strand="-" />
          </Location>
          <OMIM>104160</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_198334.3(GANAB):c.1848_1849del (p.Asp618fs)</Name>
      <CanonicalSPDI>NC_000011.10:62629280:CT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62629281" stop="62629282" display_start="62629281" display_stop="62629282" variantLength="2" positionVCF="62629280" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="62396753" stop="62396754" display_start="62396753" display_stop="62396754" variantLength="2" positionVCF="62396752" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>D377fs</ProteinChange>
      <ProteinChange>D618fs</ProteinChange>
      <ProteinChange>D504fs</ProteinChange>
      <ProteinChange>D521fs</ProteinChange>
      <ProteinChange>D526fs</ProteinChange>
      <ProteinChange>D640fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.62629281_62629282del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.62629281_62629282del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.62396753_62396754del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.62396753_62396754del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_053018.1" sequenceAccession="NG_053018" sequenceVersion="1" change="g.22445_22446del">
            <Expression>NG_053018.1:g.22445_22446del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278192.2" sequenceAccession="NM_001278192" sequenceVersion="2" change="c.1572_1573del">
            <Expression>NM_001278192.2:c.1572_1573del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265121.1" sequenceAccession="NP_001265121" sequenceVersion="1" change="p.Asp526fs">
            <Expression>NP_001265121.1:p.Asp526fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278193.2" sequenceAccession="NM_001278193" sequenceVersion="2" change="c.1506_1507del">
            <Expression>NM_001278193.2:c.1506_1507del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265122.1" sequenceAccession="NP_001265122" sequenceVersion="1" change="p.Asp504fs">
            <Expression>NP_001265122.1:p.Asp504fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278194.2" sequenceAccession="NM_001278194" sequenceVersion="2" change="c.1557_1558del">
            <Expression>NM_001278194.2:c.1557_1558del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265123.1" sequenceAccession="NP_001265123" sequenceVersion="1" change="p.Asp521fs">
            <Expression>NP_001265123.1:p.Asp521fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329222.2" sequenceAccession="NM_001329222" sequenceVersion="2" change="c.1557_1558del">
            <Expression>NM_001329222.2:c.1557_1558del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316151.1" sequenceAccession="NP_001316151" sequenceVersion="1" change="p.Asp521fs">
            <Expression>NP_001316151.1:p.Asp521fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329223.2" sequenceAccession="NM_001329223" sequenceVersion="2" change="c.1557_1558del">
            <Expression>NM_001329223.2:c.1557_1558del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316152.1" sequenceAccession="NP_001316152" sequenceVersion="1" change="p.Asp521fs">
            <Expression>NP_001316152.1:p.Asp521fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329224.2" sequenceAccession="NM_001329224" sequenceVersion="2" change="c.1125_1126del">
            <Expression>NM_001329224.2:c.1125_1126del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316153.1" sequenceAccession="NP_001316153" sequenceVersion="1" change="p.Asp377fs">
            <Expression>NP_001316153.1:p.Asp377fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329225.2" sequenceAccession="NM_001329225" sequenceVersion="2" change="c.1125_1126del">
            <Expression>NM_001329225.2:c.1125_1126del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316154.1" sequenceAccession="NP_001316154" sequenceVersion="1" change="p.Asp377fs">
            <Expression>NP_001316154.1:p.Asp377fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198334.3" sequenceAccession="NM_198334" sequenceVersion="3" change="c.1848_1849del" MANESelect="true">
            <Expression>NM_198334.3:c.1848_1849del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_938148.1" sequenceAccession="NP_938148" sequenceVersion="1" change="p.Asp618fs">
            <Expression>NP_938148.1:p.Asp618fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198335.4" sequenceAccession="NM_198335" sequenceVersion="4" change="c.1914_1915del">
            <Expression>NM_198335.4:c.1914_1915del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_938149.2" sequenceAccession="NP_938149" sequenceVersion="2" change="p.Asp640fs">
            <Expression>NP_938149.2:p.Asp640fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198335.3" sequenceAccession="NM_198335" sequenceVersion="3" change="c.1914_1915del">
            <Expression>NM_198335.3:c.1914_1915del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10586208" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="104160.0002" DB="OMIM" />
        <XRef Type="rs" ID="879255641" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_198334.3(GANAB):c.1848_1849del (p.Asp618fs) AND Polycystic kidney disease 3 with or without polycystic liver disease" Accession="RCV000239562" Version="6">
        <ClassifiedConditionList TraitSetID="31378">
          <ClassifiedCondition DB="MedGen" ID="C3887964">Polycystic kidney disease 3 with or without polycystic liver disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-30" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-06-30" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-02-25" MostRecentSubmission="2021-07-18">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27259053</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="31378" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5774" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Polycystic kidney disease 3 with or without polycystic liver disease</ElementValue>
                <XRef ID="MONDO:0010916" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE III</ElementValue>
                <XRef Type="MIM" ID="600666" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polycystic kidney disease 3</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">APKD3</ElementValue>
                <XRef Type="MIM" ID="600666" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKD3</ElementValue>
                <XRef Type="MIM" ID="600666" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal dominant polycystic kidney disease (ADPKD) is generally a late-onset multisystem disorder characterized by bilateral kidney cysts, liver cysts, and an increased risk of intracranial aneurysms. Other manifestations include: cysts in the pancreas, seminal vesicles, and arachnoid membrane; dilatation of the aortic root and dissection of the thoracic aorta; mitral valve prolapse; and abdominal wall hernias. Kidney manifestations include early-onset hypertension, kidney pain, and kidney insufficiency. Approximately 50% of individuals with ADPKD have end-stage kidney disease (ESKD) by age 60 years. The prevalence of liver cysts increases with age and occasionally results in clinically significant severe polycystic liver disease (PLD), most often in females. Overall, the prevalence of intracranial aneurysms is fivefold higher than in the general population and further increased in those with a positive family history of aneurysms or subarachnoid hemorrhage. There is substantial variability in the severity of kidney disease and other extra-kidney manifestations.</Attribute>
                <XRef ID="NBK1246" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18598" />
                <XRef ID="18598" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301424</ID>
                <ID Source="BookShelf">NBK1246</ID>
              </Citation>
              <XRef ID="C3887964" DB="MedGen" />
              <XRef ID="MONDO:0010916" DB="MONDO" />
              <XRef Type="MIM" ID="600666" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="576454" SubmissionDate="2018-02-22" DateLastUpdated="2018-02-25" DateCreated="2016-08-22">
        <ClinVarSubmissionID localKey="104160.0002_POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE" title="GANAB, 2-BP DEL, 1914AG_POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE" />
        <ClinVarAccession Accession="SCV000297927" DateUpdated="2018-02-25" DateCreated="2016-08-22" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-02-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 members of 2 unrelated families (M641 and 290100) with polycystic kidney disease-3 with or without polycystic liver disease (PKD3; 600666), Porath et al. (2016) identified a heterozygous 2-bp deletion (c.1914_1915delAG, NM_198335.3) in the GANAB gene, resulting in a frameshift and premature termination (Asp640GlnfsTer77). The mutation, which was found by Sanger sequencing of the GANAB gene, was not found in the ExAC or Exome Variant Server databases.</Attribute>
              <Citation>
                <ID Source="PubMed">27259053</ID>
              </Citation>
              <XRef DB="OMIM" ID="600666" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GANAB" />
          </GeneList>
          <Name>GANAB, 2-BP DEL, 1914AG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 1914AG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="104160.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3448182" SubmissionDate="2021-07-09" DateLastUpdated="2021-07-18" DateCreated="2021-07-18">
        <ClinVarSubmissionID localKey="NM_198335.3:c.1914_1915del|OMIM:600666" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001752706" DateUpdated="2021-07-18" DateCreated="2021-07-18" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GANAB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198335.3:c.1914_1915del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600666" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>This variant has been detected in individual(s) who were sent for testing of Renasight - kidney gene panel.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB9977930</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="576454" TraitType="Disease" MappingType="Name" MappingValue="POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE" MappingRef="Preferred">
        <MedGen CUI="C3887964" Name="Polycystic kidney disease 3 with or without polycystic liver disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448182" TraitType="Disease" MappingType="XRef" MappingValue="600666" MappingRef="OMIM">
        <MedGen CUI="C3887964" Name="Polycystic kidney disease 3 with or without polycystic liver disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

